Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 1
1985 1
1986 2
1987 1
1988 2
1989 1
1991 2
1992 4
1993 3
1994 2
1995 2
1996 6
1997 4
1998 3
1999 1
2000 3
2001 6
2002 3
2003 3
2004 7
2005 6
2006 11
2007 8
2008 6
2009 7
2010 10
2011 13
2012 11
2013 13
2014 16
2015 8
2016 14
2017 9
2018 13
2019 4
2020 16
2021 11
2022 13
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency, common variable, 5"
Page 1
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Haemoglobin values in g/dL will be calculated by multiplying haematocrit or packed cell volume values by 0.34, and studies reporting haemoglobin values in g/dL will be converted to g/L. In cluster-randomized trials, we will record the unit of randomization (e.g. hou …
Haemoglobin values in g/dL will be calculated by multiplying haematocrit or packed cell volume values by 0.34, and studies reporting haemogl …
Adult Common Variable Immunodeficiency.
Dong J, Liang H, Wen D, Wang J. Dong J, et al. Am J Med Sci. 2016 Mar;351(3):239-43. doi: 10.1016/j.amjms.2015.12.010. Am J Med Sci. 2016. PMID: 26992251
BACKGROUND: Common variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia, defective antibody production and recurrent upper and lower respiratory tract infections. ...Patients were diagnosed according to the diagnostic criteria of the Eur …
BACKGROUND: Common variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia, defective antibody produ …
Common variable immunodeficiency: an update.
Salzer U, Warnatz K, Peter HH. Salzer U, et al. Arthritis Res Ther. 2012 Sep 24;14(5):223. doi: 10.1186/ar4032. Arthritis Res Ther. 2012. PMID: 23043756 Free PMC article. Review.
Common variable immunodeficiency (CVID) describes a heterogeneous subset of hypogammaglobulinemias of unknown etiology. ...A hallmark is the impaired memory B-cell formation that has been taken advantage of for classifying CVID patients. Clinical multi
Common variable immunodeficiency (CVID) describes a heterogeneous subset of hypogammaglobulinemias of unknown etiology.
Common variable immunodeficiency-associated granulomatous and interstitial lung disease.
Prasse A, Kayser G, Warnatz K. Prasse A, et al. Curr Opin Pulm Med. 2013 Sep;19(5):503-9. doi: 10.1097/MCP.0b013e3283642c47. Curr Opin Pulm Med. 2013. PMID: 23880700 Review.
PURPOSE OF REVIEW: Common variable immunodeficiency (CVID) is the most common primary immunodeficiency characterized by a deficiency of immunoglobulins. ...Similar to sarcoidosis, granulomatous disease in CVID can potentially affect all organs, …
PURPOSE OF REVIEW: Common variable immunodeficiency (CVID) is the most common primary immunodeficiency ch …
Common variable immunodeficiency.
Cunningham-Rundles C, Maglione PJ. Cunningham-Rundles C, et al. J Allergy Clin Immunol. 2012 May;129(5):1425-1426.e3. doi: 10.1016/j.jaci.2012.03.025. J Allergy Clin Immunol. 2012. PMID: 22541363 No abstract available.
Uveitis and common variable immunodeficiency: data from the DEF-I study and literature review.
Pasquet F, Kodjikian L, Mura F, Riviere S, Harroche J, Blanc AP, Chaix F, Oksenhendler E, Seve P; DEF-I study group. Pasquet F, et al. Ocul Immunol Inflamm. 2012 Jun;20(3):163-70. doi: 10.3109/09273948.2012.674612. Epub 2012 Apr 17. Ocul Immunol Inflamm. 2012. PMID: 22506485 Review.
PURPOSE: To examine the relation between uveitis and common variable immunodeficiency (CVID). METHODS: Retrospective analysis of patients included in the French DEFI cohort of adults with CVID and of patients identified by reviewing the literature. ...Since u …
PURPOSE: To examine the relation between uveitis and common variable immunodeficiency (CVID). METHODS: Retrospective an …
Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis.
Rizvi FS, Zainaldain H, Rafiemanesh H, Jamee M, Hossein-Khannazer N, Hamedifar H, Sabzevari A, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Rizvi FS, et al. Expert Rev Clin Immunol. 2020 Dec;16(12):1227-1235. doi: 10.1080/1744666X.2021.1850272. Epub 2020 Dec 7. Expert Rev Clin Immunol. 2020. PMID: 33203275
Objectives: Common variable immunodeficiency (CVID) is the most common symptomatic inborn error of immunity characterized by variable clinical manifestations. ...The prevalences of hematologic autoimmune diseases, autoimmune gastrointesti …
Objectives: Common variable immunodeficiency (CVID) is the most common symptomatic inborn error of immunity char …
Malignancy in common variable immunodeficiency: a systematic review and meta-analysis.
Kiaee F, Azizi G, Rafiemanesh H, Zainaldain H, Sadaat Rizvi F, Alizadeh M, Jamee M, Mohammadi S, Habibi S, Sharifi L, Jadidi-Niaragh F, Haghi S, Yazdani R, Abolhassani H, Aghamohammadi A. Kiaee F, et al. Expert Rev Clin Immunol. 2019 Oct;15(10):1105-1113. doi: 10.1080/1744666X.2019.1658523. Epub 2019 Sep 15. Expert Rev Clin Immunol. 2019. PMID: 31452405
Background: Common variable immunodeficiency (CVID) is the most common clinically significant primary immunodeficiency (PID) disorder characterized by variable clinical manifestations including recurrent infections, autoimmune diso …
Background: Common variable immunodeficiency (CVID) is the most common clinically significant primary immunod
Immunoglobulin treatment in primary antibody deficiency.
Maarschalk-Ellerbroek LJ, Hoepelman IM, Ellerbroek PM. Maarschalk-Ellerbroek LJ, et al. Int J Antimicrob Agents. 2011 May;37(5):396-404. doi: 10.1016/j.ijantimicag.2010.11.027. Epub 2011 Jan 26. Int J Antimicrob Agents. 2011. PMID: 21276714 Review.
The primary antibody deficiency syndromes are characterised by recurrent respiratory tract infections and the inability to produce effective immunoglobulin (Ig) responses. The best-known primary antibody deficiencies are common variable immunodeficiency (CVID …
The primary antibody deficiency syndromes are characterised by recurrent respiratory tract infections and the inability to produce effective …
Clinical and laboratory aspects of common variable immunodeficiency.
Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV. Kokron CM, et al. An Acad Bras Cienc. 2004 Dec;76(4):707-26. doi: 10.1590/s0001-37652004000400007. Epub 2004 Nov 16. An Acad Bras Cienc. 2004. PMID: 15558152 Free article. Review.
Common variable immunodeficiency (CVID) is an immunological disorder characterized by defective antibody production, recurrent infections, most notably of the respiratory tract, autoimmune phenomena and cancer. ...In this study we discuss some of these immuno
Common variable immunodeficiency (CVID) is an immunological disorder characterized by defective antibody production, re
236 results